Procysteine data

The Cambridge, Mass., company reported results from an investigator-sponsored Phase II double blind, placebo-control study in 46 patients designed to measure the effect of Procysteine on organ dysfunction in ARDS.

The study compared Procysteine with another antioxidant designed to replenish intracellular glutathione, N-acetylcysteine (NAC), and placebo. Patients received either 189 mg/kg/day Procysteine (n=17), 210 mg/kg/day NAC (n=14), or placebo (n=15) for 10 days. ...